Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...
The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
NDA based on data from global ARROS-1 Phase 1/2 clinical trial FDA assigns PDUFA target action date of September 18, 2026 CAMBRIDGE, Mass., Nov. 19, 2025 ...
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
The U.S. Food and Drug Administration on Wednesday approved Bayer's drug for patients with a type of lung cancer.
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback